Doç. Dr. Tülay EREN

1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Seyyar M., Kalem A., Sali M., Karabuğa B., ŞAHİN T. K., Dişli A. K., et al.

Current Oncology , cilt.33, sa.6, 2026 (SCI-Expanded, Scopus)

2. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

Uysal M., Saglam S., Beypınar İ., Saglam E. K., Mammadov E., OCAK B., et al.

Cancer Investigation , cilt.44, sa.2, ss.127-135, 2026 (SCI-Expanded, Scopus)

3. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases

Zeynelgil E., Gülcü S., Koçanoğlu A., Düzköprü Y., İMAMOĞLU G. İ., EREN T.

Acta Haematologica Oncologica Turcica , cilt.58, sa.2, ss.115-120, 2025 (Scopus, TRDizin)

4. Is Hemoglobin, Albumin, Lymphocyte, and Platelet Score a Prognostic Indicator in Metastatic Squamous Cell Lung Cancer?

Doğan Ö., Düzköprü Y., Çavdar E., EREN T.

Acta Haematologica Oncologica Turcica , cilt.58, sa.1, ss.36-39, 2025 (Scopus, TRDizin)

5. Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

ŞAHİN T. K., Atalah F., Koylu B., Oruc A., Acarbay A., Karakok A., et al.

Frontiers in Immunology , cilt.16, 2025 (SCI-Expanded, Scopus)

6. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Karacin C., Oksuzoglu B., Demirci A., Keskinkılıç M., Baytemür N. K., Yılmaz F., et al.

BMC Cancer , cilt.23, sa.1, 2023 (SCI-Expanded, Scopus)

7. Percutaneous ablation treatment in metastatic lung tumors: a single-center experience

Ergun O., BİRGİ E., Hekimoğlu A., Eraslan Ö., DURMAZ H., Karaçin C., et al.

Acta Radiologica , cilt.64, sa.8, ss.2416-2423, 2023 (SCI-Expanded, Scopus)

8. Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment

Duzkopru Y., Cilbir E., İMAMOĞLU G. İ., Dogan O., EREN T.

Journal of the College of Physicians and Surgeons Pakistan , cilt.33, sa.7, ss.770-774, 2023 (SCI-Expanded, Scopus)

9. Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors

Ergun Y., Esen S. A., Bardakci M., Ucar G., Kalkan Z., Urakci Z., et al.

Cancer Biomarkers , cilt.34, sa.2, ss.329-336, 2022 (SCI-Expanded, Scopus)

10. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

Karacin C., EREN T., Zeynelgil E., İMAMOĞLU G. İ., ALTINBAŞ M., KARADAĞ İ., et al.

Future Oncology , cilt.17, sa.33, ss.4447-4456, 2021 (SCI-Expanded, Scopus)

11. Merkel cell carcinoma in Turkey: A multicentric study

YILDIZ F., DEMİRCİ U., KÜÇÜKARDA A., BÜYÜKŞİMŞEK M., Sakalar T., Topcu T., et al.

Journal of Cancer Research and Therapeutics , cilt.17, sa.6, ss.1525-1529, 2021 (SCI-Expanded, Scopus)

12. “Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?

Karacin C., Acar R., BAL Ö., EREN T., ŞENDUR M. A. N., Acikgoz Y., et al.

Supportive Care in Cancer , cilt.29, sa.8, ss.4587-4593, 2021 (SCI-Expanded, Scopus)

13. Investigation of Hereditary Cancer Predisposition Genes of Patients with Colorectal Cancer: Single-centre Experience

Duzkale N., Oz O., Turkmenoglu T. T., ÇETİNKAYA K., EREN T., YALÇIN S. S.

Journal of the College of Physicians and Surgeons Pakistan , cilt.31, sa.7, ss.811-816, 2021 (SCI-Expanded, Scopus)

14. The impact of lymph node ratio on overall survival in patients with colorectal cancer

İMAMOĞLU G. İ., OĞUZ A., Cimen S., EREN T., Karacin C., Colak D., et al.

Journal of Cancer Research and Therapeutics , cilt.17, sa.4, ss.1069-1074, 2021 (SCI-Expanded, Scopus)

15. Urethral recurrence of urothelial carcinoma of the bladder following radical cystectomy: An unusual imaging pattern

ÖZDEMİR M., Kavak R. P., EREN T.

Journal of Clinical Imaging Science , cilt.10, sa.1, ss.1-5, 2020 (ESCI, Scopus)

16. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Esin E., Oksuzoglu B., BİLİCİ A., Cicin I., KÖSTEK O., Kaplan M., et al.

Cancer Chemotherapy and Pharmacology , cilt.83, sa.1, ss.131-143, 2019 (SCI-Expanded, Scopus)

17. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

EREN T., İMAMOĞLU G. İ., Karacin C., Turker S., Cilbir E., ŞAHİNLİ H., et al.

Eastern Journal of Medicine , cilt.24, sa.4, ss.451-456, 2019 (Scopus, TRDizin)

Doç. Dr. Tülay EREN

Yayınlar & Eserler

1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

2. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

3. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases

4. Is Hemoglobin, Albumin, Lymphocyte, and Platelet Score a Prognostic Indicator in Metastatic Squamous Cell Lung Cancer?

5. Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

6. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

7. Percutaneous ablation treatment in metastatic lung tumors: a single-center experience

8. Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment

9. Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors

10. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

11. Merkel cell carcinoma in Turkey: A multicentric study

12. “Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?

13. Investigation of Hereditary Cancer Predisposition Genes of Patients with Colorectal Cancer: Single-centre Experience

14. The impact of lymph node ratio on overall survival in patients with colorectal cancer

15. Urethral recurrence of urothelial carcinoma of the bladder following radical cystectomy: An unusual imaging pattern

16. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

17. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim